78 related articles for article (PubMed ID: 15099932)
1. Effect of long-term blockade of CRF(1) receptors on exploratory behaviour, monoamines and transcription factor AP-2.
Mällo T; Berggård C; Eller M; Damberg M; Oreland L; Harro J
Pharmacol Biochem Behav; 2004 Apr; 77(4):855-65. PubMed ID: 15099932
[TBL] [Abstract][Full Text] [Related]
2. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
Harro J; Tõnissaar M; Eller M
Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
[TBL] [Abstract][Full Text] [Related]
3. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
6. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
7. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
Zieba B; Grzegorzewska M; Brański P; Domin H; Wierońska JM; Hess G; Smiałowska M
Neuropeptides; 2008; 42(5-6):513-23. PubMed ID: 18617263
[TBL] [Abstract][Full Text] [Related]
8. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
Przegaliński E; Filip M; Frankowska M; Zaniewska M; Papla I
Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885
[TBL] [Abstract][Full Text] [Related]
9. Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of corticotropin-releasing factor receptor subtype 2.
Guan X; Zhang R; Xu Y; Li S
Neuroscience; 2009 Jul; 161(3):665-70. PubMed ID: 19376201
[TBL] [Abstract][Full Text] [Related]
10. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.
Overstreet DH; Keeney A; Hogg S
Eur J Pharmacol; 2004 May; 492(2-3):195-201. PubMed ID: 15178365
[TBL] [Abstract][Full Text] [Related]
12. CRF-receptor 1 blockade attenuates acute posttraumatic hyperglycemia in rats.
Hager P; Hagman B; Wikström AC; Strömmer L
J Surg Res; 2004 Jun; 119(1):72-9. PubMed ID: 15126085
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
[TBL] [Abstract][Full Text] [Related]
14. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
[TBL] [Abstract][Full Text] [Related]
15. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Traver S; Marien M; Martin E; Hirsch EC; Michel PP
Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
Greenwood-Van Meerveld B; Johnson AC; Cochrane S; Schulkin J; Myers DA
Neurogastroenterol Motil; 2005 Jun; 17(3):415-22. PubMed ID: 15916629
[TBL] [Abstract][Full Text] [Related]
18. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
[TBL] [Abstract][Full Text] [Related]
19. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor.
Mano-Otagiri A; Iwasaki-Sekino A; Ohata H; Arai K; Shibasaki T
Neurosci Lett; 2009 May; 455(1):26-9. PubMed ID: 19429100
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats.
Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
Physiol Behav; 2006 Apr; 87(4):828-35. PubMed ID: 16545402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
